From Casetext: Smarter Legal Research

Nathan v. Takeda Pharm. Am., Inc.

UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
Oct 24, 2013
544 F. App'x 192 (4th Cir. 2013)

Opinion

No. 12-2170

10-24-2013

NOAH NATHAN, Plaintiff - Appellant, v. TAKEDA PHARMACEUTICALS AMERICA, INC.; TAKEDA PHARMACEUTICALS U.S.A., INC., f/k/a Takeda Pharmaceuticals North America, Inc., Defendants - Appellees.

ARGUED: James Alfred Bell, IV, BELL & BELL LLP, Philadelphia, Pennsylvania, for Appellant. Dana Lewis Rust, MCGUIREWOODS, LLP, Richmond, Virginia, for Appellees. ON BRIEF: Christian B. Nagel, FLUET, HUBER & HOANG, PLLC, Lake Ridge, Virginia, for Appellant. Stephanie B. Karn, Edward M. Eakin, III, MCGUIREWOODS LLP, Richmond, Virginia, for Appellees.


UNPUBLISHED

Appeal from the United States District Court for the Eastern District of Virginia, at Alexandria. Anthony J. Trenga, District Judge. (1:11-cv-01360-AJT-TRJ) Before WILKINSON and KING, Circuit Judges, and Samuel G. WILSON, United States District Judge for the Western District of Virginia, sitting by designation. Affirmed by unpublished per curiam opinion. ARGUED: James Alfred Bell, IV, BELL & BELL LLP, Philadelphia, Pennsylvania, for Appellant. Dana Lewis Rust, MCGUIREWOODS, LLP, Richmond, Virginia, for Appellees. ON BRIEF: Christian B. Nagel, FLUET, HUBER & HOANG, PLLC, Lake Ridge, Virginia, for Appellant. Stephanie B. Karn, Edward M. Eakin, III, MCGUIREWOODS LLP, Richmond, Virginia, for Appellees. Unpublished opinions are not binding precedent in this circuit. PER CURIAM:

This is an appeal by Noah Nathan ("Nathan") from the entry of summary judgment on his claims against Takeda Pharmaceuticals North America, Inc. and Takeda Pharmaceuticals America, Inc. (collectively referred to as "Takeda") for alleged violations of Title VII of the Civil Rights Act of 1964, 42 U.S.C. § 2000e, et seq. (2012). In a published memorandum decision, the district court found that Takeda was entitled to summary judgment on Nathan's claims that Takeda: (1) discriminated against him because of his status as a male caregiver; (2) subjected him to a hostile work environment; and (3) retaliated against him for engaging in protected activity. We affirm.

We review a grant of summary judgment de novo. Bonds v. Leavitt, 629 F.3d 369, 380 (4th Cir. 2011), cert. denied, 132 S. Ct. 398 (2011). Summary judgment is only appropriate when there is no genuine issue as to any material fact and the moving party is entitled to judgment as a matter of law. See Fed. R. Civ. P. 56(c); Celotex Corp. v. Catrett, 477 U.S. 317, 322 (1986). In addition, we must review the evidence in the light most favorable to the non-moving party. Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 255 (1986).

In consideration of this standard, we have carefully reviewed the issues, the record, the law, and the arguments we have heard and conclude that there is little that we can add to the thorough and well-reasoned opinion of the district court. Thus, we affirm the judgment below on the reasoning of the district court. See Nathan v. Takeda Pharm. Am., Inc., 890 F. Supp. 2d 629 (E.D. Va. 2012).

AFFIRMED


Summaries of

Nathan v. Takeda Pharm. Am., Inc.

UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
Oct 24, 2013
544 F. App'x 192 (4th Cir. 2013)
Case details for

Nathan v. Takeda Pharm. Am., Inc.

Case Details

Full title:NOAH NATHAN, Plaintiff - Appellant, v. TAKEDA PHARMACEUTICALS AMERICA…

Court:UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

Date published: Oct 24, 2013

Citations

544 F. App'x 192 (4th Cir. 2013)

Citing Cases

Tedder v. Care S. Carolina, Inc.

While temporal proximity may suffice to demonstrate the causation element of her prima facie case, it does…

Phillips v. WakeMed

For protected oppositional activity, Ms. Phillips must show either she opposed conduct that was "actually…